Mimicking Metabolic Surgery: A Non-Invasive Oral Therapy for T2D and Obesity
Time: 11:30 am
day: Conference Day Two
Details:
- Detailing GLY-200 a first-in-class, orally-administered polymer therapy designed to modulate the mucosal barrier in the GI tract, mimicking the therapeutic effects of gastric bypass surgery without the need for invasive procedures
- Examining current state of play with ongoing phase 2 trial demonstrating the potential of GLY-200 to deliver disease-modifying benefits for T2D and obesity, offering a safer, more accessible alternative to metabolic surgery
- Increasing accessibility of powerful metabolic disease treatments with non-invasive, cost-effective solution for patients who cannot undergo traditional surgical interventions
